Evidence map›Paper›PMID 29133521›Full record

Observational studyJournal of the American Heart Association2017

Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach.

Setor K Kunutsor, Lyanne M Kieneker, Stephen Burgess, Stephan J L Bakker, Robin P F Dullaart

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Setor K KunutsorTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom skk31@cantab.net.
Lyanne M KienekerDepartment of Nephrology Medicine, University of Groningen and University Medical Center, Groningen, The Netherlands.
Stephen BurgessMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
Stephan J L BakkerDepartment of Nephrology Medicine, University of Groningen and University Medical Center, Groningen, The Netherlands.
Robin P F DullaartDepartment of Endocrinology, University of Groningen and University Medical Center, Groningen, The Netherlands.
University of Groningen · NLMRC Biostatistics Unit · GBUniversity Medical Center Groningen · NLUniversity of Bristol · GB

Funding

British Heart Foundation RG/08/014/24067Medical Research Council MC_UU_00002/7Medical Research Council MR/L003120/1Wellcome Trust 204623/Z/16/Z
6 · The paper itself

Abstract

backgroundCirculating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with future hypertension risk and supplemented this with a Mendelian randomization approach to investigate any causal relevance to the association. METHODS AND

resultsPlasma total bilirubin levels were measured at baseline in the PREVEND (Prevention of Renal and Vascular End-Stage Disease) prospective study of 3989 men and women without hypertension. Hazard ratios (95% confidence intervals) of total bilirubin with incident hypertension were assessed. New-onset hypertension was recorded in 1206 participants during a median follow-up of 10.7 years. Baseline total bilirubin was approximately log-linearly associated with hypertension risk. Age- and sex-adjusted hazard ratio for hypertension per 1-SD increase in log

conclusionsThe weak and inverse association of circulating total bilirubin with future hypertension risk may be driven by biases such as unmeasured confounding and/or reverse causation. Further evaluation is warranted.

Indexed as

Risk AssessmentAdultAgedBilirubinBiomarkersBlood PressureFemaleHumansHypertensionIncidenceKidney Failure, ChronicMaleMiddle AgedNetherlandsPrognosisProspective StudiesBilirubinBiomarkersbilirubincohort studyhypertensionMendelian randomizationrisk factor

Identifiers

PMID29133521
PMCPMC5721749
OpenAlexW2769959945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.